Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9643 publications
Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.
Journal: Biomacromolecules
Published: January 19, 2026
Regioselective multicomponent synthesis of α-boryl ureas: discovery of a potent main protease inhibitor.
Journal: Organic & biomolecular chemistry
Published: January 14, 2026
Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 07, 2026
Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir.
Journal: Journal of medical economics
Published: December 13, 2025
Polypharmacy and nephrotoxicity
Journal: Innere Medizin (Heidelberg, Germany)
Published: December 05, 2025
A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 - present).
Journal: Expert opinion on therapeutic patents
Published: December 05, 2025
Computational Insights into the Regioselective Hydroxylation of Nirmatrelvir Metabolized by Cytochrome P450 3A4.
Journal: Journal of chemical information and modeling
Published: November 27, 2025
EXPRESS: Early Blood RNA Clearance and Protein Fraction Profiles Predict Treatment Outcomes in Cats with Effusive FIP.
Journal: Journal of feline medicine and surgery
Published: November 26, 2025
Risk factors associated with anti-tubercular therapy-induced hepatitis in human immunodeficiency virus seropositive and seronegative patients in India.
Journal: The International journal of risk & safety in medicine
Published: November 24, 2025
Identification and characterization of a SARS-CoV-2 M pro G23 deletion ensitrelvir-resistant mutant.
Identification and characterization of a SARS-CoV-2 M pro G23 deletion ensitrelvir-resistant mutant.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Last Updated: 02/24/2026